CORDIS
EU research results

CORDIS

English EN

Three modality contrast imaging using multi-functionalized microballoons

Project information

Grant agreement ID: 245572

Status

Closed project

  • Start date

    1 May 2010

  • End date

    30 April 2013

Funded under:

FP7-NMP

  • Overall budget:

    € 8 129 097,80

  • EU contribution

    € 5 999 412

Coordinated by:

KUNGLIGA TEKNISKA HOEGSKOLAN

Sweden

Objective

In vivo multimodality imaging is a fast growing field in medical research and, although the achievements at clinical level of this diagnostic method are recent, it is already one of the most promising approaches in the diagnosis of diseases in many research addressed medical centres. At present in this area, the USA plays the protagonist role as a result of the amount of resources engaged in the arena in the last decade. Both government and private companies agree, when considering the potential of this approach, that it is one of the foremost medical advancements as it will lead to early diagnosis of diseases with high impact on the societies of western countries. Multimodality imaging is currently viewed as a simple and powerful integration of two or more imaging methods (e.g. PET-CT). 3MICRON is an ambitious project which gathers some of the most advanced European medical and technical institutions together to address the design of new strategies in diagnostics, and to push the potential of medical imaging beyond the state-of-the-art. The multimodality approaches are supported by a class of next-generation micro/nanodevices called microballoons. These subsystems are able to implement the function of an ultrasound contrast agent with other imaging methods (SPECT, MRI). In the future, they may act as a minimally invasive drug delivery method and hyperthermia device. In 3MICRON, this multi-functional device will be tested in vitro and in vivo in order to assess bioclearance and cytoxicity effects toward high impact diseases, e.g. cardiovascular and inflammation pathologies. Finally, selected types of microballoons will undergo pre-clinical screening for a consolidated assessment of the “bench-to-bed” pathway for these new microdevices.

Coordinator

KUNGLIGA TEKNISKA HOEGSKOLAN

Address

Brinellvagen 8
100 44 Stockholm

Sweden

Activity type

Higher or Secondary Education Establishments

EU Contribution

€ 1 114 342

Administrative Contact

Peta Sjölander (Dr.)

Participants (9)

UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATA

Italy

EU Contribution

€ 449 263

UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN

Ireland

EU Contribution

€ 488 942

KAROLINSKA INSTITUTET

Sweden

EU Contribution

€ 1 072 752

FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI

Italy

EU Contribution

€ 154 154

Surflay Nanotec GmbH

Germany

EU Contribution

€ 571 626

UNIVERSITAT BAYREUTH

Germany

EU Contribution

€ 626 610

ESAOTE SPA

Italy

EU Contribution

€ 468 026

STIFTELSEN SINTEF

Norway

EU Contribution

€ 468 291

DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG

Germany

EU Contribution

€ 585 406

Project information

Grant agreement ID: 245572

Status

Closed project

  • Start date

    1 May 2010

  • End date

    30 April 2013

Funded under:

FP7-NMP

  • Overall budget:

    € 8 129 097,80

  • EU contribution

    € 5 999 412

Coordinated by:

KUNGLIGA TEKNISKA HOEGSKOLAN

Sweden